1. Home
  2. AVDL vs FAX Comparison

AVDL vs FAX Comparison

Compare AVDL & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • FAX
  • Stock Information
  • Founded
  • AVDL 2015
  • FAX 1986
  • Country
  • AVDL Ireland
  • FAX United States
  • Employees
  • AVDL N/A
  • FAX N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • FAX Investment Managers
  • Sector
  • AVDL Health Care
  • FAX Finance
  • Exchange
  • AVDL Nasdaq
  • FAX Nasdaq
  • Market Cap
  • AVDL 784.6M
  • FAX 645.2M
  • IPO Year
  • AVDL 1996
  • FAX N/A
  • Fundamental
  • Price
  • AVDL $9.43
  • FAX $15.71
  • Analyst Decision
  • AVDL Strong Buy
  • FAX
  • Analyst Count
  • AVDL 6
  • FAX 0
  • Target Price
  • AVDL $18.17
  • FAX N/A
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • FAX 833.6K
  • Earning Date
  • AVDL 05-07-2025
  • FAX 01-01-0001
  • Dividend Yield
  • AVDL N/A
  • FAX 12.09%
  • EPS Growth
  • AVDL N/A
  • FAX N/A
  • EPS
  • AVDL N/A
  • FAX N/A
  • Revenue
  • AVDL $194,450,000.00
  • FAX N/A
  • Revenue This Year
  • AVDL $55.11
  • FAX N/A
  • Revenue Next Year
  • AVDL $30.13
  • FAX N/A
  • P/E Ratio
  • AVDL N/A
  • FAX N/A
  • Revenue Growth
  • AVDL 252.64
  • FAX N/A
  • 52 Week Low
  • AVDL $6.38
  • FAX $2.33
  • 52 Week High
  • AVDL $17.30
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 58.38
  • FAX 56.20
  • Support Level
  • AVDL $8.99
  • FAX $15.36
  • Resistance Level
  • AVDL $9.31
  • FAX $15.75
  • Average True Range (ATR)
  • AVDL 0.37
  • FAX 0.21
  • MACD
  • AVDL -0.01
  • FAX 0.01
  • Stochastic Oscillator
  • AVDL 74.45
  • FAX 89.19

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

Share on Social Networks: